{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:07:35Z","timestamp":1789675655453,"version":"4.0.1"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017052","name":"National Natural Science Foundation of China-Liaoning Joint Fund","doi-asserted-by":"publisher","award":["U21A20378"],"award-info":[{"award-number":["U21A20378"]}],"id":[{"id":"10.13039\/100017052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejrad.2025.112224","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:28:00Z","timestamp":1749756480000},"page":"112224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Complications of transarterial radioembolization in hepatic malignancies: Pathophysiological insights and management paradigms"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3057-981X","authenticated-orcid":false,"given":"Mengdi","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijia","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2025.112224_b0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11894-019-0681-x","article-title":"The epidemiology of hepatocellular carcinoma in the USA","volume":"21","author":"Kim","year":"2019","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.ejrad.2025.112224_b0010","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejrad.2025.112224_b0015","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejrad.2025.112224_b0020","first-page":"e1918","article-title":"A multicenter retrospective analysis: Factors influencing hepatic adverse events induced by immunotherapy in advanced liver cancer","author":"Zou","year":"2023","journal-title":"Cancer Rep. Hoboken NJ"},{"key":"10.1016\/j.ejrad.2025.112224_b0025","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.21037\/jgo-22-626","volume":"13","author":"Wang","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0030","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/15384047.2020.1721252","article-title":"Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases","volume":"21","author":"Dagenborg","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejrad.2025.112224_b0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cam4.2673","article-title":"Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/COC.0b013e3181f47583","article-title":"Radioembolization for the treatment of liver tumors general principles","volume":"35","author":"Kennedy","year":"2012","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0045","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 Radioembolization significantly Prolongs Time to Progression Compared with Chemoembolization in patients with Hepatocellular Carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejrad.2025.112224_b0050","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jvir.2018.03.018","article-title":"Radioembolization for Hepatocellular Carcinoma: a Nationwide 10-Year Experience","volume":"29","author":"Tohme","year":"2018","journal-title":"J. Vasc. Interv. Radiol. JVIR"},{"issue":"146","key":"10.1016\/j.ejrad.2025.112224_b0055","first-page":"48","article-title":"Changing trends in hepatocellular carcinoma management: results from a nationwide database in the last decade","volume":"2021","author":"Cassinotto","year":"1990","journal-title":"Eur. J. Cancer Oxf. Engl."},{"key":"10.1016\/j.ejrad.2025.112224_b0060","first-page":"1692","article-title":"Transarterial radioembolization versus systemic treatment for hepatocellular carcinoma with macrovascular invasion: Analysis of the US National Cancer Database","volume":"62","author":"Ahn","year":"2021","journal-title":"J. Nucl. Med. off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0065","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00270-024-03768-z","article-title":"Transarterial Radioembolization (TARE) Global Practice patterns: an International Survey by the Cardiovascular and Interventional Radiology Society of Europe (CIRSE)","volume":"47","author":"Keane","year":"2024","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0070","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 2018; 69 :182\u2013236 DOI: 10.1016\/j.jhep.2018.03.019.","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"10.1016\/j.ejrad.2025.112224_b0075","doi-asserted-by":"crossref","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen Y-J, Ciombor KK, et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J. Natl. Compr. Cancer Netw. JNCCN 2018; 16 :359\u2013369 DOI: 10.6004\/jnccn.2018.0021.","DOI":"10.6004\/jnccn.2018.0021"},{"key":"10.1016\/j.ejrad.2025.112224_b0080","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.ejrad.2025.112224_b0085","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1088\/0031-9155\/45\/4\/316","article-title":"Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy","volume":"45","author":"Campbell","year":"2000","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.ejrad.2025.112224_b0090","unstructured":"Sirtex. SIRS-Spheres Yttrium-90 microspheres package insert, https:\/\/sirtex.com\/media\/55rprxv2\/ssl-us-14-sir-spheres-microspheres-ifu-us.pdf."},{"key":"10.1016\/j.ejrad.2025.112224_b0095","unstructured":"Boston Scientific. TheraSphere Instructions for Use, https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf20\/P200029C.pdf."},{"key":"10.1016\/j.ejrad.2025.112224_b0100","unstructured":"U.S. DEPARTMENT OF HEALTH AND HUMAN SEVICES. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0, https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm."},{"key":"10.1016\/j.ejrad.2025.112224_b0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/0284186X.2012.702921","article-title":"Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials","volume":"52","author":"Gafter-Gvili","year":"2013","journal-title":"Acta Oncol. Stockh. Swed."},{"key":"10.1016\/j.ejrad.2025.112224_b0110","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejrad.2025.112224_b0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0167-8140(00)00316-9","article-title":"Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders","volume":"58","author":"Weinmann","year":"2001","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ejrad.2025.112224_b0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1615\/JEnvironPatholToxicolOncol.2015013548","article-title":"Radioprotective effect of Carvacrol against X-Radiation-Induced cellular damage in cultured human peripheral blood lymphocytes","volume":"34","author":"Arivalagan","year":"2015","journal-title":"J. Environ. Pathol. Toxicol. Oncol. off. Organ Int. Soc. Environ. Toxicol Cancer"},{"key":"10.1016\/j.ejrad.2025.112224_b0130","first-page":"50","article-title":"Beyond lymphopenia, unraveling radiation-induced leucocyte subpopulation kinetics and mechanisms through modeling approaches","volume":"42","author":"Pham","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.ejrad.2025.112224_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOH.0000000000000208","article-title":"How I diagnose and treat neutropenia","volume":"23","author":"Dale","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ejrad.2025.112224_b0140","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2147\/DDDT.S299591","article-title":"A review of romiplostim mechanism of action and clinical applicability","volume":"15","author":"Bussel","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejrad.2025.112224_b0145","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","article-title":"Avatrombopag before Procedures Reduces need for Platelet Transfusion in patients with Chronic Liver Disease and Thrombocytopenia","volume":"155","author":"Terrault","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejrad.2025.112224_b0150","first-page":"1101","article-title":"Radioembolization dosimetry with total-body 90Y PET","volume":"63","author":"Costa","year":"2022","journal-title":"J. Nucl. Med. off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0155","first-page":"1047","article-title":"Tumor-absorbed Dose Predicts Progression-Free Survival following (131)I-Tositumomab Radioimmunotherapy","volume":"55","author":"Dewaraja","year":"2014","journal-title":"J. Nucl. Med. off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0160","first-page":"1557","article-title":"Quantitative Monte Carlo-based 90Y SPECT reconstruction","volume":"54","author":"Elschot","year":"2013","journal-title":"J. Nucl. Med. off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055742","article-title":"Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization","volume":"8","author":"Elschot","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejrad.2025.112224_b0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.tvir.2019.02.010","article-title":"Yttrium-90 Complications: Prevention and Management","volume":"22","author":"Titano","year":"2019","journal-title":"Tech. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0175","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-024-04573-5","article-title":"TACE vs. TARE for HCC \u2265\u20098 cm: a propensity score analysis","author":"Phan","year":"2024","journal-title":"Abdom. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.crad.2024.01.014","article-title":"Local recurrence following a complete radiologic response in hepatocellular carcinoma patients: comparison of transarterial chemoembolisation and transarterial radioembolisation","volume":"79","author":"Young","year":"2024","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0185","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/cncr.23339","article-title":"Liver disease induced by radioembolization of liver tumors: description and possible risk factors","volume":"112","author":"Sangro","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2025.112224_b0190","article-title":"Post-embolization Syndrome following Yttrium-90 Radiation Segmentectomy","volume":"15","author":"Vanani","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejrad.2025.112224_b0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3350\/cmh.2017.0004","article-title":"Radioembolization for the treatment of hepatocellular carcinoma","volume":"23","author":"Kim","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ejrad.2025.112224_b0200","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s11547-020-01180-4","article-title":"Outpatient Yttrium-90 microsphere radioembolization: assessment of radiation safety and quantification of post-treatment adverse events causing hospitalization","volume":"125","author":"Aberle","year":"2020","journal-title":"Radiol. Med. (Torino)"},{"key":"10.1016\/j.ejrad.2025.112224_b0205","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjc.6601329","article-title":"Postchemoembolisation syndrome\u2013tumour necrosis or hepatocyte injury?","volume":"89","author":"Wigmore","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejrad.2025.112224_b0210","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/NCC.0000000000000302","article-title":"Management of Postembolization Syndrome Following Hepatic Transarterial Chemoembolization for Primary or Metastatic Liver Cancer","volume":"39","author":"Blackburn","year":"2016","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.ejrad.2025.112224_b0215","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.26191","article-title":"Prognostic factors and prevention of radioembolization-induced liver disease","volume":"57","author":"Gil-Alzugaray","year":"2013","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.ejrad.2025.112224_b0220","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s00270-017-1629-x","article-title":"Safety and Efficacy of Y-90 Radioembolization after prior Major Hepatic Resection","volume":"40","author":"Zimmermann","year":"2017","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0225","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/cancers13091992","article-title":"Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease following Radioembolization","volume":"13","author":"Seidensticker","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2025.112224_b0230","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach\u2014the ALBI Grade","volume":"33","author":"Johnson","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0235","doi-asserted-by":"crossref","DOI":"10.1007\/s11547-024-01943-3","article-title":"Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)","author":"Finessi","year":"2024","journal-title":"Radiol. Med. (Torino)"},{"key":"10.1016\/j.ejrad.2025.112224_b0240","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.3390\/cancers13153794","article-title":"ALBI score is a strong Predictor of Toxicity following SIRT for Hepatocellular Carcinoma","volume":"13","author":"Lescure","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2025.112224_b0245","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.3390\/cancers13215427","article-title":"Liver Decompensation as late Complication in HCC patients with Long-Term Response following Selective Internal Radiation Therapy","volume":"13","author":"van Doorn","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2025.112224_b0250","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1002\/hep4.2072","article-title":"Hepatic decompensation after transarterial radioembolization: a retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma","volume":"6","author":"Reincke","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejrad.2025.112224_b0255","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jhep.2014.10.033","article-title":"Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6\/STAT3 signalling","volume":"62","author":"Xiao","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2025.112224_b0260","first-page":"255","article-title":"Dosimetry based on 99mTc-macroaggregated albumin SPECT\/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results","volume":"53","author":"Garin","year":"2012","journal-title":"J. Nucl. Med. off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2025.112224_b0270","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jvir.2018.09.031","article-title":"Inflammation and hypervascularization in a large animal model of knee osteoarthritis: imaging with pathohistologic correlation","volume":"30","author":"Korchi","year":"2019","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0275","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/cancers15174274","article-title":"Bilobar radioembolization carries the risk of radioembolization-induced liver disease in the treatment of advanced hepatocellular carcinoma: safety and efficacy comparison to systemic therapy with atezolizumab\/bevacizumab","volume":"15","author":"Jeschke","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2025.112224_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112731","article-title":"Prospective Randomized Trial of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid for Prevention of Radiation-Induced Liver Toxicity","volume":"9","author":"Seidensticker","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejrad.2025.112224_b0285","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9343(00)00318-1","article-title":"Ursodeoxycholic acid therapy in hepatobiliary disease","volume":"108","author":"Kowdley","year":"2000","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0290","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1378\/chest.72.3.305","article-title":"Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis","volume":"72","author":"Kennedy","year":"1977","journal-title":"Chest"},{"key":"10.1016\/j.ejrad.2025.112224_b0295","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.asjsur.2015.04.002","article-title":"Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings","volume":"39","author":"Parakh","year":"2016","journal-title":"Asian J. Surg."},{"key":"10.1016\/j.ejrad.2025.112224_b0300","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0002-9610(66)90201-7","article-title":"Newer anatomy of the liver and its variant blood supply and collateral circulation","volume":"112","author":"Michels","year":"1966","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.ejrad.2025.112224_b0305","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jvir.2023.02.030","article-title":"Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: a Comparative Study of the Effectiveness, Safety, and Dosimetry of Glass-based versus Resin-based Microspheres","volume":"34","author":"Villalobos","year":"2023","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0310","article-title":"Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejrad.2025.112224_b0315","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2011.12.012","article-title":"Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury","volume":"327","author":"Azzam","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejrad.2025.112224_b0320","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0272-5231(03)00126-6","article-title":"Pulmonary complications of radiation therapy","volume":"25","author":"Abratt","year":"2004","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0325","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejrad.2025.112224_b0330","article-title":"Classic Signaling Pathways in Alveolar Injury and Repair involved in Sepsis-Induced ALI\/ARDS: New Research Progress and Prospect","volume":"2022","author":"Li","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ejrad.2025.112224_b0335","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.matbio.2015.05.006","article-title":"The extracellular matrix and transforming growth factor-\u03b21: Tale of a strained relationship","volume":"47","author":"Hinz","year":"2015","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.ejrad.2025.112224_b0340","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00099-20","article-title":"The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejrad.2025.112224_b0345","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejrad.2025.112224_b0350","doi-asserted-by":"crossref","first-page":"437","DOI":"10.21873\/anticanres.14793","article-title":"Liver function changes after technetium-99m-macroaggregated albumin administration and their predictive value regarding hepatotoxicity in patients undergoing yttrium-90-radioembolization","volume":"41","author":"Fabritius","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejrad.2025.112224_b0355","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12880-020-00452-9","article-title":"Unexpected radiation pneumonitis after SIRT with significant decrease in DLCO with internal radiation exposure: a case report","volume":"20","author":"Kesim","year":"2020","journal-title":"BMC Med. Imaging"},{"key":"10.1016\/j.ejrad.2025.112224_b0360","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0365","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jvir.2009.05.030","article-title":"Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review","volume":"20","author":"Riaz","year":"2009","journal-title":"J. Vasc. Interv. Radiol. JVIR"},{"key":"10.1016\/j.ejrad.2025.112224_b0370","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jvir.2008.01.003","article-title":"Biliary sequelae following radioembolization with Yttrium-90 microspheres","volume":"19","author":"Atassi","year":"2008","journal-title":"J. Vasc. Interv. Radiol. JVIR"},{"key":"10.1016\/j.ejrad.2025.112224_b0375","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.brachy.2013.05.008","article-title":"Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: an evaluation of 112 patients","volume":"12","author":"Peterson","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ejrad.2025.112224_b0380","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-0031-1280671","article-title":"Hepatic radioembolization complicated by radiation cholecystitis","volume":"28","author":"Hickey","year":"2011","journal-title":"Semin. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0385","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2214\/AJR.13.10548","article-title":"Yttrium-90 radioembolization of malignant tumors of the liver: gallbladder effects","volume":"202","author":"Sag","year":"2014","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2025.112224_b0390","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.pop.2017.07.002","article-title":"Gallbladder Dysfunction: Cholecystitis, Choledocholithiasis, Cholangitis, and Biliary Dyskinesia","volume":"44","author":"Wilkins","year":"2017","journal-title":"Prim. Care"},{"key":"10.1016\/j.ejrad.2025.112224_b0395","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.2022.2350","article-title":"Acute Cholecystitis: a Review","volume":"327","author":"Gallaher","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ejrad.2025.112224_b0400","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM194910272411703","article-title":"Acute gangrenous cholecystitis","volume":"241","author":"Clifford","year":"1949","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0405","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.radcr.2024.04.097","article-title":"Diagnosis and management of radiation cholecystitis as a complication of Y90 radioembolization for hepatocellular carcinoma","volume":"19","author":"Khoury","year":"2024","journal-title":"Radiol. Case Rep."},{"key":"10.1016\/j.ejrad.2025.112224_b0410","first-page":"351","article-title":"Extra-hepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver","volume":"35","author":"Thamboo","year":"2003","journal-title":"Pathology (Phila.)"},{"issue":"64","key":"10.1016\/j.ejrad.2025.112224_b0415","first-page":"2783","article-title":"Cholecystitis induced by Yttrium-90 radioembolization of advanced liver tumors: prospective evaluation of a management algorithm in 197 consecutive patients","volume":"2023","author":"Damm","year":"1987","journal-title":"Acta Radiol. Stockh. Swed."},{"key":"10.1016\/j.ejrad.2025.112224_b0420","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00270-012-0474-1","article-title":"Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery","volume":"36","author":"Theysohn","year":"2013","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0425","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11547-018-00984-9","article-title":"Safety of transarterial radioembolization with Yttrium-90 glass microspheres without cystic artery occlusion","volume":"124","author":"Topcuoglu","year":"2019","journal-title":"Radiol. Med. (Torino)"},{"key":"10.1016\/j.ejrad.2025.112224_b0430","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00270-015-1088-1","article-title":"Prophylactic embolization of the cystic artery prior to radioembolization of liver malignancies\u2013an evaluation of necessity","volume":"38","author":"Powerski","year":"2015","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0435","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00259-009-1279-6","article-title":"First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation","volume":"37","author":"Garin","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2025.112224_b0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvir.2016.09.024","article-title":"Radioembolization of Hepatic Malignancies: Background, Quality Improvement guidelines, and Future Directions","volume":"28","author":"Padia","year":"2017","journal-title":"J. Vasc. Interv. Radiol. JVIR"},{"key":"10.1016\/j.ejrad.2025.112224_b0445","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-0041-1735605","article-title":"Biliary-Caval Fistula following Y90 Radioembolization","volume":"38","author":"Hall","year":"2021","journal-title":"Semin. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0450","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MOG.0000000000000632","article-title":"Radiation enteritis: from diagnosis to management","volume":"36","author":"Hale","year":"2020","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.ejrad.2025.112224_b0455","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clon.2009.10.003","article-title":"Chronic Radiation enteritis","volume":"22","author":"Theis","year":"2010","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0460","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","article-title":"Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience","volume":"65","author":"Kennedy","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejrad.2025.112224_b0465","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1445-2197.2006.03834.x","article-title":"Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients","volume":"76","author":"Stubbs","year":"2006","journal-title":"ANZ J. Surg."},{"key":"10.1016\/j.ejrad.2025.112224_b0470","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tem.2023.05.006","article-title":"Gut microbiota controlling radiation-induced enteritis and intestinal regeneration","volume":"34","author":"Moraitis","year":"2023","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"10.1016\/j.ejrad.2025.112224_b0475","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwad044","article-title":"Radiation injury and gut microbiota-based treatment","volume":"15","author":"Wang","year":"2023","journal-title":"Protein Cell"},{"key":"10.1016\/j.ejrad.2025.112224_b0480","article-title":"An unmet need for pharmacology: Treatments for radiation-induced gastrointestinal mucositis","volume":"175","author":"Zhou","year":"2024","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.ejrad.2025.112224_b0485","first-page":"189","article-title":"Magnetic resonance enterography findings of chronic radiation enteritis","volume":"11","author":"Algin","year":"2011","journal-title":"Cancer Imaging off Publ. Int. Cancer Imaging Soc."},{"key":"10.1016\/j.ejrad.2025.112224_b0490","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00535-012-0539-6","article-title":"Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded","volume":"47","author":"Khor","year":"2012","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ejrad.2025.112224_b0495","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10151-015-1372-8","article-title":"The histopathological mimics of inflammatory bowel disease: a critical appraisal","volume":"19","author":"Woodman","year":"2015","journal-title":"Tech. Coloproctology"},{"key":"10.1016\/j.ejrad.2025.112224_b0500","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/PAS.0b013e31817ed787","article-title":"Selective Internal Radiation Therapy-induced Extrahepatic Injury: an Emerging Cause of Iatrogenic Organ damage","volume":"33","author":"Crowder","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ejrad.2025.112224_b0505","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/PAS.0000000000001901","article-title":"Gastrointestinal Tract Injury by Yttrium-90 Appears Largely Restricted to Resin Microspheres but can Occur Years after Embolization","volume":"46","author":"Feely","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ejrad.2025.112224_b0510","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00330-015-4076-6","article-title":"Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis","volume":"26","author":"Pieper","year":"2016","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0515","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/cco.2019.12.15","article-title":"Interventional radiology approaches for intra-hepatic cholangiocarcinoma","volume":"9","author":"Mosconi","year":"2020","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110244","article-title":"Preparation and characterization of inorganic radioactive holmium-166 microspheres for internal radionuclide therapy","volume":"106","author":"Arranja","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejrad.2025.112224_b0525","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1021\/acs.molpharmaceut.4c00138","article-title":"Ultrastable PLGA-Coated 177Lu-Microspheres for Radioembolization Therapy of Hepatocellular Carcinoma","volume":"21","author":"Jin","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejrad.2025.112224_b0530","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000028","article-title":"Biodegradable 131Iodine-Labeled Microspheres: potential Transarterial Radioembolization Biomaterial for Primary Hepatocellular Carcinoma Treatment","volume":"9","author":"Pang","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejrad.2025.112224_b0535","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.semnuclmed.2019.01.005","article-title":"Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET","volume":"49","author":"Tafti","year":"2019","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0540","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diii.2022.12.002","article-title":"Lung shunt fraction calculations before Y-90 transarterial radioembolization: Comparison of accuracy and clinical significance of planar scintigraphy and SPECT\/CT","volume":"104","author":"Young","year":"2023","journal-title":"Diagn. Interv. Imaging"},{"key":"10.1016\/j.ejrad.2025.112224_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.radphyschem.2020.109080","article-title":"Collimator and energy window optimization for practical imaging protocol and quantification of Yttrium-90 bremsstrahlung spect\/ct: a phantom study","volume":"178","author":"Huey","year":"2021","journal-title":"Radiat. Phys. Chem."},{"key":"10.1016\/j.ejrad.2025.112224_b0550","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00259-023-06567-9","article-title":"MIDOS: a novel stochastic model towards a treatment planning system for microsphere dosimetry in liver tumors","volume":"51","author":"Huesa-Berral","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2025.112224_b0555","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222891","article-title":"Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma","volume":"309","author":"Hsieh","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112224_b0560","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1053\/j.gastro.2021.12.276","article-title":"AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma","volume":"162","author":"Su","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejrad.2025.112224_b0565","doi-asserted-by":"crossref","unstructured":"M K, Rs F, S Q, Kh H, K I, F P, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet Lond. Engl. 2018; 391 DOI: 10.1016\/S0140-6736(18)30207-1.","DOI":"10.1016\/S0140-6736(18)30207-1"},{"key":"10.1016\/j.ejrad.2025.112224_b0570","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0575","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2022.11.017","article-title":"Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population","volume":"180","author":"Casadei-Gardini","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejrad.2025.112224_b0580","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ejrad.2025.112224_b0585","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.annonc.2024.03.005","article-title":"Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040\u2606","volume":"35","author":"Melero","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0590","doi-asserted-by":"crossref","unstructured":"H P, M B, M DB, E A, J G, Jp B, et al. Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial). Eur. J. Cancer Oxf. Engl. 1990 2021; 154 DOI: 10.1016\/j.ejca.2021.05.032.","DOI":"10.1016\/j.ejca.2021.05.032"},{"key":"10.1016\/j.ejrad.2025.112224_b0595","doi-asserted-by":"crossref","unstructured":"N M, E R, R E, Vk B, F C, S S, et al. Cost-utility analysis of selective internal radiation therapy with Y-90 resin microspheres in hepatocellular carcinoma. Future Oncol. Lond. Engl. 2021; 17 DOI: 10.2217\/fon-2020-1004.","DOI":"10.2217\/fon-2020-1004"},{"key":"10.1016\/j.ejrad.2025.112224_b0600","first-page":"187","article-title":"Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: a preliminary report of safety and feasibility","volume":"6","author":"Yu","year":"2023","journal-title":"J. Interv. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0605","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1200\/JCO.21.01839","article-title":"Radioembolization with Chemotherapy for Colorectal Liver Metastases: a Randomized, Open-Label, International, Multicenter, phase III Trial","volume":"39","author":"Mulcahy","year":"2021","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0610","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0615","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","article-title":"Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study","volume":"7","author":"Kim","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2025.112224_b0620","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","article-title":"First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials","volume":"18","author":"Wasan","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0625","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jvir.2013.02.031","article-title":"Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis","volume":"24","author":"Mouli","year":"2013","journal-title":"J. Vasc. Interv. Radiol. JVIR"},{"key":"10.1016\/j.ejrad.2025.112224_b0630","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jvir.2011.12.253","article-title":"Abstract No. 205: short-term outcomes of intrahepatic cholangiocarcinoma treated with glass based yttrium 90 microspheres","volume":"23","author":"Shridhar","year":"2012","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0635","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00259-023-06111-9","article-title":"Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study","volume":"50","author":"Kokabi","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2025.112224_b0640","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1148\/radiol.2020202321","article-title":"US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: a Randomized pilot Clinical Trial","volume":"298","author":"Eisenbrey","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112224_b0645","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00270-018-1985-1","article-title":"90Y Resin Microspheres Radioembolization for Colon Cancer Liver Metastases using Full-Strength Contrast Material","volume":"41","author":"Kurilova","year":"2018","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.ejrad.2025.112224_b0650","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/COC.0b013e3182a78dba","article-title":"Radioembolization with Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: a Multicenter prospective Study","volume":"38","author":"Kim","year":"2015","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0655","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/cncr.29275","article-title":"Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis","volume":"121","author":"Kokabi","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2025.112224_b0660","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jhep.2014.03.023","article-title":"Prospective randomized pilot study of Y90+\/-sorafenib as bridge to transplantation in hepatocellular carcinoma","volume":"61","author":"Kulik","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2025.112224_b0665","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1245\/s10434-014-4164-x","article-title":"Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? a large single-center experience of 302 patients","volume":"22","author":"Saxena","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0670","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12032-017-1021-3","article-title":"Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis","volume":"34","author":"Floridi","year":"2017","journal-title":"Med. Oncol. Northwood Lond. Engl."},{"key":"10.1016\/j.ejrad.2025.112224_b0675","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","article-title":"SIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma","volume":"36","author":"Chow","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0680","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.66.1181","article-title":"SIRFLOX: Randomized phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in patients with Metastatic Colorectal Cancer","author":"van Hazel","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0685","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/bjc.2014.344","article-title":"Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer","volume":"111","author":"Cohen","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejrad.2025.112224_b0690","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005457","article-title":"Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study","volume":"10","author":"de la Torre-Al\u00e1ez","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejrad.2025.112224_b0695","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-009-0777-x","article-title":"Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option","volume":"17","author":"Saxena","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0700","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1158\/1078-0432.CCR-23-0581","article-title":"A phase I\/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for locally Advanced Unresectable Hepatocellular Carcinoma","volume":"29","author":"Lee","year":"2023","journal-title":"Clin. Cancer Res. off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ejrad.2025.112224_b0705","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1148\/radiol.211806","article-title":"90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: results from the TRACE phase II Randomized Controlled Trial","volume":"303","author":"Dhondt","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112224_b0710","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1186\/s12885-022-10401-0","article-title":"Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases","volume":"22","author":"Fidelman","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejrad.2025.112224_b0715","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jhep.2019.08.006","article-title":"Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma","volume":"71","author":"Ricke","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2025.112224_b0720","article-title":"Radiation pneumonitis following Yttrium-90 radioembolization: a Korean multicenter study","volume":"13","author":"Kim","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2025.112224_b0725","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1413724","article-title":"A Woman with Black Beads in her Stomach: Severe Gastric Ulceration Caused by Yttrium-90 Radioembolization","volume":"2018","author":"Voruganti","year":"2018","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.ejrad.2025.112224_b0730","article-title":"Gastric Ulcer with Yttrium-90 Microsphere Selective Internal Radiation Therapy","volume":"16","author":"Mushtaq","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ejrad.2025.112224_b0735","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2015.10.016","article-title":"Microvascular injury in persistent gastric ulcers after yttrium-90 microsphere radioembolization for liver malignancies","volume":"50","author":"Sun","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ejrad.2025.112224_b0740","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00270-015-1139-7","article-title":"Gastric Perforation following Prophylactic Embolization of right Gastric and Gastroduodenal arteries prior to Selective Internal Radiation Therapy","volume":"38","author":"Shukla","year":"2015","journal-title":"Cardiovasc. Intervent. Radiol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25003109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25003109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T17:41:14Z","timestamp":1753292474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X25003109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":148,"alternative-id":["S0720048X25003109"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112224","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications of transarterial radioembolization in hepatic malignancies: Pathophysiological insights and management paradigms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112224"}}